Pipeline coverage: how much pipeline you actually need to hit plan
“We need three times the target in pipeline” sounds decisive until the deals are late, loosely qualified, concentrated in one partner, or too large for the team to deliver. Real coverage is the amount of stage-qualified, time-eligible pipeline your own sales system needs to produce the remaining number. This guide shows you how to calculate it, find the gap, and turn the gap into work.

Start with the remaining number
Coverage begins with the revenue still unaccounted for in the plan period. Do not use the full annual target if signed recurring revenue, renewals, or committed work already covers part of it. Do not subtract an opportunity merely because someone said yes verbally. Define what “committed” means in your finance and sales process.
Write the equation in plain language:
`Revenue gap = plan-period target minus revenue already committed for that period`
Then separate the gap by revenue type if the routes behave differently. New logos, expansions, renewals, and one-off projects can have different values, conversion patterns, and sales cycles. One combined coverage number hides the work.
For market entry, isolate the destination-market gap. Home-market deals should not make a new-country plan look covered. If the new market is expected to contribute only after a certain month, place the revenue in the periods when it can actually be recognized.
The output is not a motivational target. It is the specific amount the open pipeline must still produce within a defined window.
Define stages by evidence
Coverage is only as credible as the stages beneath it. If a salesperson can move an opportunity to “proposal” because a document was emailed, the stage describes seller activity rather than buying progress.
Give every stage an observable entry and exit. Discovery may require a meeting with a relevant problem owner and a confirmed problem. Qualified may require fit, budget route, timing, buying process, and an accepted next step. Proposal may require scope discussed with the buying group, not merely sent.
Keep the stage set short enough to use. More labels do not create more truth. The critical distinction is whether the account has shown evidence that the purchase is moving.
Apply one definition to direct, inbound, founder-led, and partner opportunities. If partner “pipeline” uses looser rules, report it separately until the underlying accounts meet your stages.
Calculate conversion from your own history
For each stage, measure the share of opportunities that became the revenue event used in the plan. Use the same unit throughout. If the target is signed annual contract value, the conversion endpoint should be signed annual contract value. If it is recognized revenue this quarter, timing and delivery need to be included.
Use a relevant historical window. Remove corrupted periods only with a written reason, such as a discontinued product or a stage definition that changed. Segment when the routes differ materially. Founder introductions may convert differently from cold demand. A mature home market may differ from a first international market.
When there is no destination-market history, do not import confidence from another market without a discount. Use the closest comparable cohort as a planning hypothesis, label it, and replace it as local evidence arrives. A range is more honest than one false-precision percentage.
The basic stage-weighted value is:
`Expected value = open opportunity value multiplied by observed stage-to-win rate`
This is a planning estimate across a portfolio, not a prediction that one named deal will partially close.
Make time eligibility explicit
An opportunity can be real and still be unable to produce revenue in the plan window. Check the time from current stage to signature, then from signature to revenue recognition or delivery.
For each open deal, compare the required close date with the observed time remaining from its stage. Include procurement, legal, security, onboarding, implementation, and any client calendar constraint. “Decision this quarter” is not enough if the implementation needed for revenue begins next quarter.
Mark opportunities as time-eligible, at risk, or outside the window. Keep the latter in the broader pipeline, but exclude them from coverage for the current plan. This one step often explains why a dashboard looks healthy while the quarter still feels exposed.
New-market plans need extra care. Early conversations are also testing the offer, proof, and route. Do not force them into a home-market close calendar simply because the board target needs it.
Use value that can survive the deal
Opportunity value should reflect the scope the account is actually considering. A maximum product configuration, unapproved expansion, or multi-year headline should not cover a near-term target unless the stage evidence supports it.
Define the value field. It might be first-year contract value, gross revenue in the plan period, or gross margin. Choose the measure that matches the business plan and use it consistently. If delivery capacity or margin is the real constraint, revenue alone can give the wrong answer.
Apply scenario values when scope is unresolved. Use a credible base case in coverage and retain the upside separately. Record the reason for any value change so the dashboard does not rise because estimates drifted.
For partners, confirm whether reported value is end-client contract value, your net revenue, or a distributor purchase. These are not interchangeable.
Calculate required pipeline without a universal multiplier
A single multiplier can be a useful shorthand after the system is understood. It should be the output of your conversion and timing, not a borrowed rule.
At one stage, the simple requirement is:
`Required stage value = revenue gap divided by stage-to-win rate`
If the gap is $200,000 and the relevant cohort historically converts 25 percent of properly qualified value into the defined revenue event, the starting requirement at that stage is $800,000. This is arithmetic, not a benchmark. Change the conversion input and the requirement changes.
In a multi-stage open pipeline, calculate expected value opportunity by opportunity or cohort by cohort, then sum only the time-eligible amount. Compare that with the revenue gap. Coverage ratio alone is less useful than the expected-value gap and the work required to fill it.
Do not blend raw lead volume with qualified value. Leads are an input to pipeline creation and need their own conversion chain.
Build a coverage table the team can inspect
The minimum useful table exposes value, probability basis, timing, and concentration.
| Coverage view | Calculation | What it tells you | What it can hide |
|---|---|---|---|
| Raw coverage | Open value divided by revenue gap | Total value present | Weak stages and late deals |
| Stage-weighted coverage | Sum of value times observed stage rate, divided by gap | Portfolio expectation | Differences by source and market |
| Time-eligible coverage | Weighted value able to land in period, divided by gap | Current plan support | Delivery or recognition constraints |
| Source-adjusted view | Time-eligible value split by source cohort | Dependence on one route | Small samples |
| Capacity-adjusted view | Eligible value capped by selling and delivery capacity | Whether the team can process and serve it | Sudden hiring or delivery changes |
The table should be drillable to the accounts. A coverage number with no route back to opportunity evidence cannot be challenged or improved.
Find the creation gap by stage
Once time-eligible weighted pipeline is compared with the revenue gap, the shortfall becomes a pipeline-creation requirement.
`Expected-value gap = revenue gap minus time-eligible weighted pipeline`
To translate that into needed pipeline at a chosen stage:
`New stage value needed = expected-value gap divided by the conversion rate from that stage`
Then work backward to the activity that creates that stage. If qualified opportunities usually come from discovery conversations, calculate the needed discoveries using the observed discovery-to-qualified rate. Continue back only as far as the team can act.
This is where marketing and sales meet. The number should become a defined account, offer, channel, and follow-up plan, not an instruction to “generate more leads.”
Separate coverage by source and market
Two pipelines with the same total can carry different risk. One may be distributed across repeatable inbound and outbound routes. The other may depend on a founder relationship or one distributor.
Report source cohorts separately when conversion, cycle, value, or control differs. Inbound demand, direct account work, events, referrals, partners, and founder-led opportunities should not inherit one average without evidence.
For market entry, keep the destination market separate until it has enough history to justify blending. Tag origin, destination, sector, partner, and account cohort where those facts change the buying route. The goal is not more dashboard slices. It is to avoid borrowing a mature route’s probability for an unproven one.
Concentration also matters within a source. If one opportunity carries most of the expected value, show the plan with and without it.
Add selling and delivery capacity
Pipeline can exceed the team’s ability to progress it. A salesperson with too many live evaluations delays follow-up and reduces the conversion assumptions used to claim coverage. A delivery team with no capacity may push start dates outside the revenue window.
Measure active opportunities per owner by stage and required work. A technical evaluation may consume more capacity than several early discoveries. Set a practical work-in-progress limit from observed team performance and inspect exceptions weekly.
Check production behind the seller. Account research, proposals, proof, campaigns, partner materials, and reporting need owners. A senior lead without the people who ship this work becomes the bottleneck.
Finally, test delivery. If the plan assumes ten wins but operations can start four, the commercial coverage is not plan coverage. Change timing, capacity, scope, or target explicitly.
Worked example
Worked example: a hypothetical new-market quarter
This example uses invented planning inputs for arithmetic only. It does not claim a Folmia client outcome or a market benchmark.
A B2B company needs $300,000 of new-market contract value signed this quarter. It has $60,000 already committed under the company’s finance definition, leaving a $240,000 revenue gap.
The open destination-market pipeline contains two late-stage opportunities totaling $200,000 and four qualified opportunities totaling $400,000. From the closest comparable cohort, the team uses a 60 percent late-stage win hypothesis and a 25 percent qualified-stage hypothesis. After checking timing, only $150,000 of the late-stage value and $280,000 of qualified value can plausibly sign in the quarter.
The weighted time-eligible value is $90,000 from late stage plus $70,000 from qualified, or $160,000. The expected-value gap is therefore $80,000. At a 25 percent qualified-to-win hypothesis, the company needs another $320,000 of genuinely qualified, time-eligible value, unless it improves another input.
The conclusion is not “find $320,000 anywhere.” The team checks whether enough target accounts can enter qualification in time, whether the sellers can handle them, and whether delivery can support the resulting wins. If not, the honest options are to change the plan period, change the target, increase capacity, or create a faster valid offer.
Turn the gap into weekly work
Assign the gap to routes with owners. One part may come from named-account work, one from inbound follow-up, and one from partners. Each route needs a stage-creation target based on its own observed conversion, not a shared lead target.
The marketing team produces the accounts, offer, campaign, proof, event work, and follow-up system needed to create qualified conversations. The sales team handles discovery, qualification, buying-group progress, and commercial next steps. Both inspect the same revenue gap every week.
Review leading evidence without confusing it with coverage. Account engagement, replies, meetings booked, and proposals produced explain whether the creation system is working. Only stage-qualified, time-eligible value covers the plan.
Drop weak work while it is still cheap. If a channel creates meetings that do not become qualified, change the accounts, message, offer, or route before increasing volume.
Failure modes that make coverage lie
The universal multiplier. Every company, market, source, and stage receives the same “3x” rule. The number feels simple but has no relationship to actual conversion or timing.
Seller activity used as stage evidence. Sending a proposal advances the opportunity even though the buying group has not accepted scope or process. Tighten the exit criteria.
Late pipeline counted in full. Real deals outside the plan window reassure the current quarter. Separate broader pipeline from time-eligible coverage.
Partner numbers accepted unopened. A distributor reports value without accounts, stages, or next actions. Exclude it until it meets the shared definition.
One large deal carries the plan. The weighted total looks sufficient, but one decision contains most of it. Show concentration and the no-deal scenario.
Capacity omitted. Marketing creates more demand than sales can process, or sales closes work delivery cannot start. Coverage must survive both constraints.
When the answer is to change the plan
Sometimes the calculation shows that no credible amount of new activity can close the gap in time. That is useful information.
Change the plan when the required opportunity volume exceeds the reachable account set, the necessary stage progression is faster than observed cycles, or delivery cannot recognize the resulting revenue. Do not repair arithmetic by raising probabilities without evidence.
The options are concrete. Move revenue to a later period, reduce the target, increase qualified capacity, change the offer to a valid faster entry point, or accept more risk explicitly. Leadership should choose among those options rather than asking the pipeline report to hide them.
For a new market, stopping or extending the learning period can protect more capital than forcing a quarterly target onto unproved routes.
The weekly coverage review
The review starts with the remaining number, then examines time-eligible weighted coverage and the creation gap. It inspects changes in stage evidence, value, close timing, source, concentration, and capacity.
Every material change needs a reason. A deal moved because the buying group accepted the next step, not because the seller wanted a cleaner forecast. A value changed because scope changed, not because the plan was short.
The meeting ends with work: accounts to research, proof to produce, opportunities to progress, partners to challenge, and assumptions to replace. Owners and dates are recorded. The next review begins with whether that work shipped and what the market did in response.
Continue your market entry planning
Frequently asked questions
Is three times pipeline coverage enough?
There is no universal answer. Divide the revenue gap by your relevant stage-to-win rate, then adjust for timing, source, value, concentration, and capacity. The resulting multiplier is yours and can change by cohort.
Should we use weighted pipeline in the forecast?
Use it as a portfolio planning view when the stage rates are based on relevant evidence. Keep the underlying opportunities visible and do not treat a weighted fraction of one deal as a promise.
What if we have no conversion history in the new market?
Use the closest comparable cohort as a labeled range, apply a confidence discount, and replace it as destination-market evidence arrives. Keep the new market separate from mature-market coverage.
Do proposals count as pipeline?
Only if the opportunity has met your evidence-based stage rule. A document sent without confirmed scope, buying process, and next action is seller activity, not stronger coverage.
How often should coverage be reviewed?
Weekly for an active revenue plan. The review should change account, offer, channel, follow-up, or capacity work. Daily movement can be monitored without turning the team into forecast administrators.
What should the future calculator output?
At minimum: remaining revenue gap, raw and time-eligible weighted coverage, expected-value gap, required new value by chosen stage, concentration warning, and the assumptions used. It should show ranges when the evidence is weak.
Bring us the target and the current pipeline.
We will rebuild the coverage view from your stages, timing, sources, and capacity, then run the marketing and sales work needed to close the creation gap.
Map the coverage gapFolmia Marketing Teams are available starting from $2,000/month, Sales Teams are available starting from $3,000/month, and Market Entry Teams are available starting from $5,000/month. Every offer is a senior lead plus the people who do the work, with weekly numbers and cancel-anytime terms.
